And so it goes on, yet another reason why the 4000%+ higher price of currently used auto-immune and cancer treatments vs Low Dose Naltrexone (LDN) cannot be ignored any longer. The potential billions of pounds in savings here make the millions required for LDN clinical trials a sound investment for the NHS in Scotland and the UK as a whole.
http://bit.ly/SPLDNcost
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment